LLY compared with SRPT: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

SRPTSarepta Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

SRPTSarepta Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only SRPT 9

ARWRArrowheadsupplier

BMRNBioMarinsupplier

—Catalentunlistedsupplier

—Brammer Bio MA, LLC, an affiliate of Thermo Fisher Scientific, Inc. ("Thermo")

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

5 more · SRPT chain ›

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

SRPTSarepta Therapeutics, Inc.

17.54▼−7.65%· post 17.18

ClosedNov 5 '26

Mkt cap$2.0BRevenue$381MQ3 FY26Revenue$2.2BFY25

Compare

ClosedNov 5 '26

LLYELI Lilly & Co

SRPTSarepta Therapeutics, Inc.

1,371.32▼−3.29%post 1,363.77

Price

17.54▼−7.65%post 17.18

$1.2T

Mkt cap

$2.0B

Q3 FY26$24.4B

Revenue

$381MQ3 FY26

FY25$65.2B

Revenue

$2.2BFY25

LLY1,371.32▼−3.29%vsSRPT17.54▼−7.65%ClosedNov 5 '26